Cargando…

Targeted In Vivo Mutagenesis in Yeast Using CRISPR/Cas9 and Hyperactive Cytidine and Adenine Deaminases

[Image: see text] Directed evolution is a preferred strategy to improve the function of proteins such as enzymes that act as bottlenecks in metabolic pathways. Common directed evolution approaches rely on error-prone PCR-based libraries where the number of possible variants is usually limited by cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Skrekas, Christos, Limeta, Angelo, Siewers, Verena, David, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10443040/
https://www.ncbi.nlm.nih.gov/pubmed/37486333
http://dx.doi.org/10.1021/acssynbio.2c00690
_version_ 1785093737099034624
author Skrekas, Christos
Limeta, Angelo
Siewers, Verena
David, Florian
author_facet Skrekas, Christos
Limeta, Angelo
Siewers, Verena
David, Florian
author_sort Skrekas, Christos
collection PubMed
description [Image: see text] Directed evolution is a preferred strategy to improve the function of proteins such as enzymes that act as bottlenecks in metabolic pathways. Common directed evolution approaches rely on error-prone PCR-based libraries where the number of possible variants is usually limited by cellular transformation efficiencies. Targeted in vivo mutagenesis can advance directed evolution approaches and help to overcome limitations in library generation. In the current study, we aimed to develop a high-efficiency time-controllable targeted mutagenesis toolkit in the yeast Saccharomyces cerevisiae by employing the CRISPR/Cas9 technology. To that end, we fused the dCas9 protein with hyperactive variants of adenine and cytidine deaminases aiming to create an inducible CRISPR-based mutagenesis tool targeting a specific DNA sequence in vivo with extended editing windows and high mutagenesis efficiency. We also investigated the effect of guide RNA multiplexing on the mutagenesis efficiency both phenotypically and on the DNA level.
format Online
Article
Text
id pubmed-10443040
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-104430402023-08-23 Targeted In Vivo Mutagenesis in Yeast Using CRISPR/Cas9 and Hyperactive Cytidine and Adenine Deaminases Skrekas, Christos Limeta, Angelo Siewers, Verena David, Florian ACS Synth Biol [Image: see text] Directed evolution is a preferred strategy to improve the function of proteins such as enzymes that act as bottlenecks in metabolic pathways. Common directed evolution approaches rely on error-prone PCR-based libraries where the number of possible variants is usually limited by cellular transformation efficiencies. Targeted in vivo mutagenesis can advance directed evolution approaches and help to overcome limitations in library generation. In the current study, we aimed to develop a high-efficiency time-controllable targeted mutagenesis toolkit in the yeast Saccharomyces cerevisiae by employing the CRISPR/Cas9 technology. To that end, we fused the dCas9 protein with hyperactive variants of adenine and cytidine deaminases aiming to create an inducible CRISPR-based mutagenesis tool targeting a specific DNA sequence in vivo with extended editing windows and high mutagenesis efficiency. We also investigated the effect of guide RNA multiplexing on the mutagenesis efficiency both phenotypically and on the DNA level. American Chemical Society 2023-07-24 /pmc/articles/PMC10443040/ /pubmed/37486333 http://dx.doi.org/10.1021/acssynbio.2c00690 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Skrekas, Christos
Limeta, Angelo
Siewers, Verena
David, Florian
Targeted In Vivo Mutagenesis in Yeast Using CRISPR/Cas9 and Hyperactive Cytidine and Adenine Deaminases
title Targeted In Vivo Mutagenesis in Yeast Using CRISPR/Cas9 and Hyperactive Cytidine and Adenine Deaminases
title_full Targeted In Vivo Mutagenesis in Yeast Using CRISPR/Cas9 and Hyperactive Cytidine and Adenine Deaminases
title_fullStr Targeted In Vivo Mutagenesis in Yeast Using CRISPR/Cas9 and Hyperactive Cytidine and Adenine Deaminases
title_full_unstemmed Targeted In Vivo Mutagenesis in Yeast Using CRISPR/Cas9 and Hyperactive Cytidine and Adenine Deaminases
title_short Targeted In Vivo Mutagenesis in Yeast Using CRISPR/Cas9 and Hyperactive Cytidine and Adenine Deaminases
title_sort targeted in vivo mutagenesis in yeast using crispr/cas9 and hyperactive cytidine and adenine deaminases
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10443040/
https://www.ncbi.nlm.nih.gov/pubmed/37486333
http://dx.doi.org/10.1021/acssynbio.2c00690
work_keys_str_mv AT skrekaschristos targetedinvivomutagenesisinyeastusingcrisprcas9andhyperactivecytidineandadeninedeaminases
AT limetaangelo targetedinvivomutagenesisinyeastusingcrisprcas9andhyperactivecytidineandadeninedeaminases
AT siewersverena targetedinvivomutagenesisinyeastusingcrisprcas9andhyperactivecytidineandadeninedeaminases
AT davidflorian targetedinvivomutagenesisinyeastusingcrisprcas9andhyperactivecytidineandadeninedeaminases